GENOME ANNOUNCEMENT
===================

In the last decade, a new hypervirulent (hypermucoviscous) variant of *Klebsiella pneumoniae* has been described ([@B1]). Most isolates of hypervirulent *K. pneumoniae* are very susceptible to antimicrobials (except ampicillin). However, a multidrug-resistant and hypervirulent variant of *K. pneumoniae* has also been described as the next "superbug" ([@B2]). On the other hand, *Klebsiella variicola* is a Gram-negative rod of the *Enterobacteriaceae* family; it was described as a new bacterial species in 2004 ([@B3]). Currently, *K. variicola* is known to be an endophyte of plants ([@B3], [@B4]), a symbiont in insects ([@B5]), and a pathogen in humans ([@B3]). A susceptible and multiresistant phenotype of *K. variicola* has been identified, corresponding to an extended spectrum β-lactamase (ESBL)--producing *K. variicola*, encoding the SHV-type and CTX-M-15 genes ([@B6], [@B7]).

It is difficult to distinguish *K. variicola* from *K. pneumoniae* biochemically as bacterial species. Therefore, it is necessary to use molecular tools such as the *rpoB* analysis. Accordingly, our teamwork developed a multiplex PCR assay for the proper differentiation of these sister bacteria ([@B7]). Using this molecular tool, a screening for antibiotic-susceptible and multiresistant *K. pneumoniae* clinical isolates was carried out in several Mexican hospitals ([@B7]). As a result, the susceptible *K. variicola* clinical isolate 8917 was identified. This isolate was obtained from the sputum of a 76-year-old man at the Hospital Regional Centenário de la Revolución Mexicana in Morelos, Mexico, in 2011. This isolate was initially identified as a susceptible (except to ampicillin) *K. pneumoniae* isolate using a MicrosScan Walkaway system (Dade Behring, West Sacramento, CA, USA). Subsequently, it was identified as *K. variicola* using the M-PCR-1; this was confirmed by the phylogeny analysis of the *rpoB* gene ([@B7]). The hypermucoviscous phenotype of *Klebsiella variicola* isolate 8917 was determined using the semiquantitative string test ([@B8]) and then was considered for whole-genome sequencing.

A total genomic sample of *K. variicola* isolate 8917 was extracted and purified using the DNeasy kit (Qiagen, Germany). The whole-genome sequence was generated using pyrosequencing on the 454 Roche FLX Titanium platform. The sequence data totaled 250,217 reads, with a range in length of 30 to 953 bp. Reads longer than 500 bp were used for *de novo* assembly with the CLC Genomics Workbench version 4.0 (CLC bio). In total, 103 contigs with an *N*~50~ of 257,189 bp were obtained. The estimated genome size was 5,686,491 bp with a 20× coverage, and 99.93% of the bp were above Q40. Gene prediction and annotation were carried out using the bioinformatic MicroScope platform ([@B9]). A total of 5,621 coding DNA sequences and 65 tRNA genes were determined. The BLAST searching analysis of the *magA*, *rmpA*, and *rmpA2* genes described in hypervirulent *K. pneumoniae* turned out to be negative on the hypermucoviscous *K. variicola* 8917 genome. However, the following virulence-associated determinants were positive with different amino acid identities: *uge* (99.10%), *ureA* (100%), *wabG* (99.47%), *iroN* (64.9%), *iutA* (72.9%), *kfuABC* (\>98.6%), *mceG* (53.1%), *mrkABCDFHIJ* (\>86.8%), and *entB* (99.6) and a nucleotide identity of 100% with wzc-932 (serotype). Further analyses are required to identify the genes involved in the hypermucoviscous phenotype on *K. variicola* clinical isolate 8917.

Nucleotide sequence accession number. {#s1}
-------------------------------------

The annotated genome sequence is available at the European Nucleotide Archive under the accession number [CEGG01000001](http://www.ebi.ac.uk/ena/data/view/CEGG01000001).
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